Attn: Grace, a female-founded company specializing in incontinence care, has raised an additional $2M in funding led by For Later and joined by Flybridge, as well as existing investors like Kapor Capital, Portfolia, Ingeborg Investments, and Commonwealth. The funding comes on the heels of Attn: Grace’s recent expansion into nearly 1,600 Walmart Supercenters across the United States, along with its presence on…
VICHY Laboratoires, a renowned skincare brand, has partnered with Embr Labs, a leading healthtech company to bring a much needed holistic approach to menopause care and wellness. The collaboration combines VICHY’s expertise in skincare with Embr Labs’ innovative wellness technology, providing women with a comprehensive approach to managing menopausal symptoms. VICHY Laboratoires’ Neovadiol line, designed for peri- and post-menopausal skin, includes products…
San Francisco-based Bone Health Technologies (BHT) has presented pivotal trial data for its novel treatment Osteoboost at the renowned endocrinology conference, Endo 2023. The double-blind study enrolled 126 postmenopausal women with low bone mass, focusing on the effectiveness of Osteoboost in reducing the decline of bone strength and density. The Osteoboost device, which is seeking FDA’s Class 2 Prescription De Novo Approval,…
Vistagen, a biopharma company focused on developing treatments for anxiety, depression, and other central nervous system disorders, has announced positive results from an exploratory Phase 2A study of PH80 in women diagnosed with menopausal hot flashes. The study, which involved 36 participants, demonstrated statistically significant efficacy of PH80 nasal spray compared to a placebo. The Phase 2A clinical study was designed to…
Kindra, the US-based wellness brand specializing in menopause essentials, is expanding into the UK. Aiming to cater to the needs of 13 million women seeking hormone-free menopause solutions, the company’s products will be available on OurKindra.co.uk from June 15, followed by a debut on QVC UK on June 17, and on Amazon.co.uk by mid-July. Kindra’s Founder & CEO, Catherine Balsam-Schwaber, shares: “The…
Bolstering their focus on women’s health, US-based Cosette Pharmaceuticals has acquired the global rights to Intrarosa from Endoceutics, a subsidiary of Endorecherche. Intrarosa is a drug for the treatment of moderate-to-severe dyspareunia, a common symptom of vulvar and vaginal atrophy (VVA) due to menopause. According to Cosette Pharmaceuticals it is unique for being the only prescription drug providing both estrogen and androgen.…
We last spoke about Astellas Pharma in February, when the company made headlines with its menopause ad that ran during the Superbowl LVII in the US. The ad focused on vasomotor symptoms (VMS), which are hot flashes and night sweats associated with menopause. Now the company is back with more news regarding its efforts in the menopause space as the FDA has…
Introduction Menopause is a natural phase of a woman’s life that marks the end of her reproductive years. Along with hormonal changes, menopause brings about various physical and emotional symptoms. One of the most common and bothersome symptoms experienced during menopause are Vasomotor Symptoms (VMS). In this comprehensive guide, we will delve deep into the world of VMS, exploring its causes, symptoms,…
